A clozapine-like effect of cyproheptadine on progressive ratio schedule performance

Journal of Psychopharmacology

Volumn 26, Issue 6, 2012, Pages 857-870

  Olarte Sanchez C M ^a   Valencia Torres, L ^a   Body, S ^a   Cassaday, H J ^a   Bradshaw, C M ^a   Szabadi, E ^a   Goudie, A J ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

9 tetrahydrocannabinol; atypical antipsychotics; chlordiazepoxide; clozapine; cyproheptadine; haloperidol; progressive ratio schedule; rats; reinforcer efficacy

Indexed keywords

CHLORDIAZEPOXIDE; CLOZAPINE; CYPROHEPTADINE; DRONABINOL; HALOPERIDOL; HISTAMINE H1 RECEPTOR; SEROTONIN 2 RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOOD INTAKE; INSTRUMENTAL CONDITIONING; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REINFORCEMENT;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CHLORDIAZEPOXIDE; CLOZAPINE; CONDITIONING, OPERANT; CYPROHEPTADINE; EATING; FEMALE; HALOPERIDOL; MOTIVATION; PERFORMANCE-ENHANCING SUBSTANCES; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; TETRAHYDROCANNABINOL;

EID: 84862129654     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881111408961     Document Type: Article

References (73)

1. Abel EL. Cannabis: effects on hunger and thirst. Behav Biol. 1975 ; 15: 255-281
2. Aberman JE, Ward SJ, Salamone JD. Effects of dopamine antagonists and accumbens dopamine depletions on time-constrained progressive-ratio performance. Pharmacol Biochem Behav. 1998 ; 61: 341-348
3. Akhondzadeh S, Mohammedi M, Amini-Nooshabadi H, Davari-Ashtiani R. Cyproheptadine in treatment of chronic schizophrenia: a double-blind placebo-controlled study. J Clin Pharm Ther. 1999 ; 24: 49-52
4. Arnold J, Roberts DCS. A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol Biochem Behav. 1997 ; 57: 441-447
5. Barr AM, Philips AG. Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement. Psychopharmacology. 1998 ; 141: 99-106
6. Bacher NM, Sabzone MM, Kauo B. Cyproheptadine in treatment resistant chronic schizophrenics with prior negative response to fluoxetine. J Clin Psychopharmac. 1994 ; 14: 424-425
7. Berridge KC, Treit D. Chlordiazepoxide directly enhances positive ingestive reactions in rats. Pharmacol Biochem Behav. 1986 ; 24: 217-221
8. Bezzina G, Body S, Cheung THC, Hampson CL, Deakin JFW, Anderson IM, et al. Effect of quinolinic acid-induced lesions of the nucleus accumbens core on performance on a progressive ratio schedule of reinforcement: implications for inter-temporal choice. Psychopharmacology. 2008a ; 197: 339-350
9. Bezzina G, den Boon FS, Hampson CL, Cheung THC, Body S, Bradshaw CM, et al. Effect of quinolinic acid-induced lesions of the subthalamic nucleus on performance on a progressive ratio schedule of reinforcement: a quantitative analysis. Behav Brain Res. 2008b ; 195: 223-230
10. Bizo LA, Killeen PR. Models of ratio schedule performance. J Exp Psychol: Anim Behav Proc. 1997 ; 23: 351-367
11. Bizo LA, Kettle LC, Killeen PR. Rats don't always respond faster for more food. Anim Learn Behav. 2001 ; 29: 66-78
12. Bymaster F, Calligaro D, Falcone J, Marsh R, Moore N, Tye N, et al. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacol. 1996 ; 14: 87-96
13. Cador M, Taylor JR, Robbins TW. Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens. Psychopharmacology. 1991 ; 104: 377-385
14. Chaudhry I, Soni S, Hellewell J, Deakin JFW. Effects of the 5-HT antagonist cyproheptadine on neuropsychological function in chronic schizophrenia. Schizophrenia Res. 2002 ; 53: 17-24
15. Cheeta S, Brooks S, Willner P. Effects of reinforcer sweetness and the D2/D3 antagonist raclopride on progressive ratio operant responding. Behav Pharmacol. 1995 ; 6: 127-132
16. Cilia J, Piper DC, Upton N, Hagan JJ. Clozapine enhances breakpoint in common marmosets responding on a progressive ratio schedule. Psychopharmacology. 2001 ; 155: 135-143
17. Comer S, Haney M, Fischman M, Foltin R. Cyproheptadine produced modest increases in total caloric intake by humans. Physiol Behav. 1997 ; 62: 831-839
18. Cooper SJ Seminars in Psychopharmacology. 2004 ) Anxiolytics, sedatives and hypnotics. In: KingDJ (ed.) Seminars in Psychopharmacology, second ed.London: Gaskell, 141-177. King DJ, ed. London: Gaskell ; 2004: 141-177.
19. Corrigan PW, Reinke RR, Landsberger SA, Charate A, Toombs GA. The effects of atypical antipsychotic medications on psychosocial outcomes. Schizophrenia Res. 2003 ; 63: 97-101
20. Cunningham Owens DG A Guide to the Extrapyramidal Side Effects of Antipsychotic Drugs. Cambridge: Cambridge University Press ; 1999 :
21. Freet CS, Tesche JD, Tompers DM, Riegel KE, Grigson PS. Lewis rats are more sensitive than Fischer rats to successive negative contrast, but less sensitive to the anxiolytic and appetite-stimulating effects of chlordiazepoxide. Pharmacol Biochem Behav. 2006 ; 85: 378-384
22. Goudie AJ, Cooper GD, Cole JC, Sumnall HR. Cyproheptadine resembles clozapine in vivo following both acute and chronic administration in rats. J Psychopharmacol. 2007 ; 21: 179-190
23. Hamill S, Trevitt JT, Nowend KL, Carlson BB, Salamone JD. Nucleus accumbens dopamine depletion and time-constrained progressive ratio performance: effects of different ratio requirements. Pharmacol Biochem Behav. 1999 ; 64: 21-27
24. Hartfield A, Moore N, Clifton P. Serotonergic and histaminergic mechanisms involved in intralipid drinking. Pharmacol Biochem Behav. 2003 ; 76: 251-258
25. Heyman GM. A parametric evaluation of the hedonic and motoric effects of drugs: pimozide and amphetamine. J Exp Anal Behav. 1983 ; 40: 113-122
26. Higgs S, Barber DJ, Cooper AJ, Terry P. Differential effects of two cannabinoid receptor antagonists on progressive ratio responding for food and free-feeding in rats. Behav Pharmac. 2005 ; 16: 389-393
27. Ho M-Y, Body S, Kheramin S, Bradshaw CM, Szabadi E. Effects of 8-OH-DPAT and WAY-100635 on performance on a time-constrained progressive ratio schedule. Psychopharmacology. 2003 ; 167: 137-144
28. Hodos W. Progressive ratio as a measure of reward strength. Science. 1961 ; 134: 943-944
29. Hodos W, Kalman G. Effects of increment size and reinforcer volume on progressive ratio performance. J Exp Anal Behav. 1963 ; 6: 389-392
30. Ichikawa J, Ishii H, Bonaccorsco S, Fowler WL, O'Laughlin IA, Meltzer HY. 5-HT2A and D2 receptor blockade increases cortical DA release via 5-HT1A receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem. 2001 ; 76: 1521-1531
31. Jarrett MM, Limebeer CL, Parker LA. Effect of Δ9- tetrahydrocannabinol on sucrose palatability as measured by the taste reactivity test. Physiol Behav. 2005 ; 86: 475-479
32. Kapur S, Zipursky R, Jones C, Remington G, Houle S. Relationship between dopamine D2 occupancy, clinical response, and side-effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiat. 2000 ; 157: 514-520
33. Ketelaars C, Bruinvels J. The anti-conflict effect of cyproheptadine is not mediated by its 5-hydroxytryptamine antagonistic property. Life Sci. 1989 ; 44: 1743-1749
34. Kheramin S, Body S, Miranda Herrera F, Bradshaw CM, Szabadi E, Deakin JFW, et al. The effect of orbital prefrontal cortex lesions on performance on a progressive ratio schedule: implications for models of inter-temporal choice. Behav Brain Res. 2005 ; 156: 145-152
35. Killeen PR. Mathematical principles of reinforcement. Behav Brain Sci. 1994 ; 17: 105-172
36. Killeen PR, Sitomer MT. MPR. Behav Proc. 2003 ; 62: 49-64
37. Killeen PR, Posadas-Sanchez D, Johansen EB, Thrailkill EA. Progressive ratio schedules of reinforcement. J Exp Psychol: Anim Behav Proc. 2009 ; 35: 35-50
38. King DJ, Waddington JL Seminars in Psychopharmacology. 2004 ) Antipsychotic drugs and the treatment of schizophrenia. In: KingDJ (ed.) Seminars in Psychopharmacology, second ed.London: Gaskell, 316-380. King DJ, ed. London: Gaskell ; 2004: 316-380.
39. Kirkham TC, Williams . Synergistic effects of opioid and cannabinoid antagonists on food intake. Psychopharmacology. 2001 ; 153: 267-270
40. Koch JE. Δ9-THC stimulates food intake in Lewis rats: Effects on chow, high-fat and sweet high-fat diets. Pharmacol Biochem Behav. 2001 ; 68: 539-543
41. Lee H, Song D, Kim J, Lee Y, Han E, Yoo K. Cyproheptadine augmentation of haloperidol in chronic schizophrenic patients: a double-blind placebo-controlled study. Int Clin Psychopharmacol. 1995 ; 10: 67-72
42. Meltzer H, Matsubara S, Lee J-C. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin-2 pKi values. J Pharmac Exp Ther. 1989 ; 251: 238-246
43. MeltzerHY (1995) The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics. J Clin Psychopharmacol15(Suppl 1): 2S-3S.
44. Meltzer H, Perry E, Jayathilake K. Clozapine-induced weight gain predicts improvement in psychopathology. Schizophrenia Res. 2003 ; 59: 19-27
45. Mobini S, Chiang T-J, Ho M-Y, Bradshaw CM, Szabadi E. Comparison of the effects of clozapine, haloperidol, chlorpromazine and d-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rat. Psychopharmacology. 2000 ; 152: 47-54
46. Moore N, Tye N, Axton M, Risius F. The behavioral pharmacology of olanzapine, a novel 'atypical' antipsychotic agent. J Pharmacol Exp Ther. 1992 ; 262: 545-551
47. Morley MJ, Bradshaw CM, Szabadi E. The effects of pimozide on variable-interval performance: a test of the 'anhedonia' hypothesis of the mode of action of neuroleptic drugs. Psychopharmacology. 1984 ; 84: 531-536
48. Müller-Spahn F. Current use of atypical antipsychotics. Eur Psychiat. 2002 ; 17: 377-384
49. Reilly MP. Extending mathematical principles of reinforcement into the domain of behavioral pharmacology. Behav Proc. 2003 ; 62: 75-88
50. Rickard JF, Body S, Zhang Z, Bradshaw CM, Szabadi E. Effect of reinforcer magnitude on performance maintained by progressive ratio schedules. J Exp Anal Behav. 2009 ; 91: 75-87
51. Roberts DCS, Richardson NR Neuromethods, vol 24: Animal Models of Drug Addiction. Boulton A Baker G Wu PH, ed. New York: Humana ; 1992: 233-269.
52. Rowlett JK. A labor-supply analysis of cocaine self-administration under progressive ratio schedules: antecedents, methodologies, and perspectives. Psychopharmacology. 2000 ; 153: 1-16
53. Salamone JD. Different effects of haloperidol and extinction on instrumental behaviors. Psychopharmacology. 1986 ; 88: 18-23
54. Salamone JD Handbook of Psychopharmacology. Iversen LL Iversen SD Snyder SH, ed. New York: Plenum ; 1987: 575-608.
55. Salamone JD, Cousins MS, Butcher S. Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure. Behav Brain Res. 1994 ; 65: 221-229
56. Salamone JD, Cousins MS, Snyder BJ. Behavioral functions of nucleus accumbens dopamine: Empirical and conceptual problems with the anhedonia hypothesis. Neurosci Biobehav Rev. 1997 ; 21: 341-359
57. Seeman P, Lee T, Chau WM, Wong K. Antipsychotic drug dose and neuroleptic/dopamine receptors. Nature. 1976 ; 261: 717-719
58. Silver H, Blacker M, Weller M, Lerer B. Treatment of chronic schizophrenia with cyproheptadine. Biol Psychiatry. 1989 ; 25: 502-504
59. Silver H, Blacker M, Weller M, Lerer B. Treatment of chronic schizophrenia with cyproheptadine: a double-blind placebo-controlled study. Biol Psychiatry. 1991 ; 30: 523-525
60. Skjoldager P, Pierre PJ, Mittleman G. Reinforcer magnitude and progressive ratio responding in the rat: effects of increased effort, prefeeding, and extinction. Learn Motiv. 1993 ; 24: 303-343
61. Stafford D, Branch MN. Effects of step size and break-point criterion on progressive ratio performance. J Exp Anal Behav. 1998 ; 70: 123-138
62. Stafford D, LeSage MG, Glowa JR. Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review. Psychopharmacology. 1998 ; 139: 169-184
63. TestDiet. Technical data sheet on grain-based rodent tablet 5TUM. www.testdiet.com.
64. Ward SJ, Dykstra LA. The role of CB1 receptors in sweet versus fat reinforcement: Effect of CB1 receptor depletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940). Behav Pharmacol. 2005 ; 16: 381-388
65. Williams CM, Kirkham TC. Observational analysis of feeding induced by Δ9-THC and anandamide. Physiol Behav. 2002 ; 76: 241-250
66. Williams CM, Rogers PJ, Kirkham TC. Hyperphagia in pre-fed rats following oral Δ9-THC. Physiol Behav. 1998 ; 65: 343-346
67. Wise RA. Neuroleptics and operant behavior: the anhedonia hypothesis. Brain Behav Sci. 1982 ; 5: 39-87
68. Wise RA. Role of brain dopamine in food reward and reinforcement. Philos Trans R Soc Lond B Biol Sci. 2006 ; 361: 1149-1158
69. Wise RA, Rompre P-P. Brain dopamine and reward. Ann Rev Psychol. 1989 ; 40: 191-225
70. Wise RA, Spindler J, de Wit H, Gerber GJ. Neuroleptic-induced 'anhedonia' in rats: pimozide blocks the reward quality of food. Science. 1978 ; 201: 262-264
71. Young R, Khorana N, Bondareva T, Glennon R. Pizotyline effectively attenuates the stimulus effects of N-methyl-3,4-methylenedioxyamphetamine (MDMA). Pharmacol Biochem Behav. 2005 ; 82: 404-410
72. Zhang Z, Rickard JF, Asgari K, Body S, Bradshaw CM, Szabadi E. Quantitative analysis of the effects of some "atypical" and "conventional" antipsychotics on progressive ratio schedule performance. Psychopharmacology. 2005a ; 179: 489-497
73. Zhang Z, Rickard JF, Asgari K, Body S, Bradshaw CM, Szabadi E. Comparison of the effects of clozapine and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on progressive ratio schedule performance: evidence against the involvement of 5-HT1A receptors in the behavioural effects of clozapine. Psychopharmacology. 2005b ; 181: 381-391